Product Information
BUPROPION HCL XL 150 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0787 per EA under NDC 16729044310. Its NADAC has been published 402 times since Dec 12, 2018.
FDA first approved this application on Oct 31, 2018. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729044310
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210497FDA Approved
10/31/2018
TE Code
AB3
On Market Since
11/8/2018
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL XL 150 MG TABLET has been published 402 times since Dec 12, 2018, and over the history we have for it it has declined 71.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0787 per EA |
|---|---|
| All-time high | $0.3117 (Aug 14, 2019) |
| All-time low | $0.0745 (Nov 20, 2024) |
| 52-week high | $0.1015 |
| 52-week low | $0.0770 |
| Median price | $0.1168 |
| Average price | $0.1446 |
| Largest weekly change | -30.3% (Nov 20, 2024) |
| Weeks tracked | 402 |
| Tracking since | Dec 12, 2018 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPROPION HCL XL 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 150 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0787 per EA (NDC 16729044310), effective Aug 19, 2026.
How has the price of BUPROPION HCL XL 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL XL 150 MG TABLET has declined 71.9%. It has been tracked across 402 weekly CMS publications since Dec 12, 2018.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 150 MG TABLET?
Since Dec 12, 2018, the NADAC for BUPROPION HCL XL 150 MG TABLET has ranged from a low of $0.0745 (Nov 20, 2024) to a high of $0.3117 (Aug 14, 2019), with a median of $0.1168 per EA.
Are there cheaper alternatives to BUPROPION HCL XL 150 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0770 per EA — about 2% below BUPROPION HCL XL 150 MG TABLET.
Who manufactures BUPROPION HCL XL 150 MG TABLET?
BUPROPION HCL XL 150 MG TABLET (NDC 16729044310) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.